Antimicrobial Stewardship
Antimicrobial stewardship concerns the actions that healthcare providers and healthcare systems take to manage and administer antimicrobial drugs safely and effectively.
Effective antimicrobial stewardship ensures that patients, both human and animal, receive the most effective treatment option. According to the Pew Charitable Trusts, this approach improves patient outcomes, saves money, and enables providers to prescribe the right drug at the right time for the right length of time.
What Is Antimicrobial Stewardship?
Antimicrobial stewardship (AMS) refers to the responsibility shared by all healthcare providers and systems globally to administer antimicrobial drugs in ways that protect the long-term health of people, animals, and the planet. This effort most often focuses on antibiotic resistance, but antimicrobial drugs also include the broader group of drug agents that treat infection and sepsis, including antibiotics, antifungals, and antiseptics.
Antimicrobial stewardship is a shared responsibility to optimize antimicrobial use — improving patient outcomes while reducing the emergence of resistance. It involves coordinated interventions designed to improve and measure the appropriate use of antimicrobial agents across healthcare settings, from hospitals and long-term care facilities to outpatient clinics and veterinary practices.
Antimicrobial Stewardship Programs
For decades, AMS programs have been working to ensure the proper use of antimicrobials. A 2005 article on antimicrobial stewardship programs from the Virginia Commonwealth University School of Pharmacy defines an antimicrobial stewardship program as "an ongoing effort by a health care institution to optimize antimicrobial use among hospitalized patients in order to improve patient outcomes, ensure cost-effective therapy, and reduce adverse sequelae of antimicrobial use (including antimicrobial resistance)."
Institutions around the world have implemented Antimicrobial Stewardship Programs (ASPs) — structured policies to track, monitor, and report on antimicrobial usage and resistance patterns. These programs operate in hospitals, long-term care facilities, and outpatient clinics, reducing C. difficile infections, shortening hospital stays, and lowering healthcare costs.
Understanding and mitigating resistance is urgent because the pace of microbial resistance is outpacing new drug development. AMS programs equip providers with the tools they need to develop policies and procedures for prescribing drug treatments, guidance on how to track, monitor, and report on their progress, and instruction for establishing ongoing patient and provider education programs.
The 4 Ds of Antimicrobial Therapy
Antimicrobial Stewardship Programs equip individuals, healthcare providers, and institutions with the tools to manage the effective use of antimicrobial drugs. The Centers for Medicare and Medicaid Services (CMS), the CDC, the Society for Healthcare Epidemiology of America (SHEA), and the Joint Commission developed AMS standards for hospitals and nursing homes. They defined the goals of any AMS program as educating healthcare providers to follow the 4 D's of antimicrobial therapy.
Right Drug
Select the most appropriate antimicrobial agent based on the specific pathogen and susceptibility profile.
Right Dose
Ensure the correct dosage to achieve therapeutic levels without contributing to toxicity or resistance.
Right Duration
Limit treatment to the minimum effective duration to reduce selection pressure on resistant organisms.
Right De-escalation
Narrow or discontinue therapy as soon as clinical data supports it, moving from broad to targeted treatment.
A 2019 regulation from CMS required all US hospitals to develop AMS programs by March 2020. The CDC's Core Elements of Hospital Antibiotic Stewardship Programs provide evidence-based guidelines for healthcare providers, including hospitals, outpatient services, and nursing homes. Across all these groups, the core elements of successful implementation are:
Commitment & Accountability
Facility- and location-specific leadership and individual providers must commit to establishing and following best practices. Leaders must allocate the time and resources needed to support ongoing stewardship efforts.
Policy-Based Action
Define and implement interventions that improve antimicrobial and antibiotic use. These can include prospective audit and feedback, preauthorization, and evidence-based treatment recommendations.
Tracking & Reporting
Monitor prescribing patterns, intervention impacts, and patient outcomes to enforce accountability at all levels — from individual prescribers to the institutional leadership overseeing stewardship programs.
Educate & Develop Expertise
Ongoing case-based education programs are needed to educate prescribers, pharmacists, and nurses about optimal prescribing. Patient education is also crucial to reduce demand for unnecessary antimicrobial treatments.
Examples of Antimicrobial Stewardship Programs
AMS programs operate at every level — from individual hospitals to global institutions. Here are examples of the coordinated efforts underway to combat antimicrobial resistance:
State Programs
- Minnesota Department of Health — statewide antimicrobial stewardship collaborative
- New Jersey Department of Health — healthcare-associated infection prevention program
National Programs
- CDC Core Elements — evidence-based guidelines for hospitals, outpatient services, and nursing homes
- Infectious Diseases Society of America (IDSA) Centers for Excellence — 163 programs since 2017 launch
- American Animal Hospital Association (AAHA) and American Veterinary Medical Association (AVMA) — veterinary stewardship guidelines
Global Programs
- WHO Global Action Plan on AMR — the international framework for coordinated stewardship efforts
- World AMR Awareness Week — annual campaign coordinated by FAO, UNEP, WHO, and WOAH
- OpenWHO.org — free antimicrobial stewardship courses for healthcare professionals worldwide
- OneHealth Trust — WHO Collaborating Center for AMR, bridging human and animal health stewardship
Why Are Stewardship Programs Important?
Antimicrobial resistance (AMR) is a global health issue. Without ongoing and coordinated efforts at the state, national, and global levels, we face a reality in which major surgeries cannot be conducted and people will die from treatable infections.
Antimicrobial stewardship programs are necessary due to the rising threat of AMR and the slow pace of new drug development. Without intervention, we risk entering a post-antibiotic era where common infections become untreatable. Effective stewardship reduces unnecessary treatments, lowers healthcare costs, minimizes adverse drug events, and — most critically — slows the development of resistant organisms.
The Cost of Inaction
Without effective stewardship, AMR is projected to kill 10 million people annually by 2050 and cost the global economy up to $100 trillion. These numbers underscore the urgency of coordinated antimicrobial stewardship programs worldwide.
Biomeme's Role in Antimicrobial Stewardship
Biomeme's rapid molecular diagnostics support stewardship by providing the "right diagnosis" quickly — enabling the 4 Ds from the very start of treatment. By differentiating viral from bacterial infections at the point of care, clinicians can avoid unnecessary antibiotic prescriptions and make targeted treatment decisions in real time.
Our mobile, field-deployable platforms bring molecular testing directly to the point of need — supporting antimicrobial stewardship not only in hospitals but in resource-limited settings, veterinary clinics, and field operations where access to laboratory infrastructure is constrained. This aligns with the One Health approach to antimicrobial stewardship, bridging human, animal, and environmental health.
Learn About Host Response DiagnosticsExplore Our Molecular Solutions
Learn how rapid molecular diagnostics can support your antimicrobial stewardship program and improve patient outcomes.
Get in Touch